<ѻýҕl>Hemoglobin Targets a Good Idea for Massively Transfused Patientsѻýҕl> Outcomes improved with values approaching 10 g/dL Oct 16, 2023
<ѻýҕl>Suzanne Somers Dies; FDA Plans to Ban Hair Relaxers; Health Worker Minimum Wageѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Oct 16, 2023
<ѻýҕl>Study Validates Accuracy of PREDICT Prognostication Tool in Breast Cancerѻýҕl> Findings suggest it's a suitable decision aid for U.S. oncologists and patients Oct 13, 2023
<ѻýҕl>Cryoprecipitate, REBOA Flop for Improving Major Hemorrhage Outcomesѻýҕl> The first randomized trials of both approaches failed Oct 13, 2023
<ѻýҕl>Hair Relaxers' Cancer Risk; Genetic Test Aids Rural Care; Drug Negotiation Fallout?ѻýҕl> News, features, and commentary about cancer-related issues Oct 13, 2023
<ѻýҕl>New Lung Cancer Cases Are Higher in Younger Women vs Menѻýҕl> And the higher incidence rates now extend to women ages 50 to 54 as well Oct 12, 2023
<ѻýҕl>Combination Therapy Wins FDA Approval for BRAF-Mutated NSCLCѻýҕl> Encorafenib plus binimetinib led to 75% ORR in untreated patients, 59% in treated patients Oct 12, 2023
<ѻýҕl>'Abortion Test' Sparks Concern; AI in Brain Surgery; 'Is There a Doctor on Board?'ѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Oct 12, 2023
<ѻýҕl>Rare Lung Bleeds Cluster in DOAC Users, Implications Unclearѻýҕl> Pattern found in diffuse alveolar hemorrhage reports in FAERS Oct 11, 2023
<ѻýҕl>Primary Care Intervention Improved Follow-Up of Abnormal Cancer Screening Resultsѻýҕl> Follow-up testing within 120 days was improved with EHR reminders, patient outreach, navigation Oct 10, 2023
<ѻýҕl>HER3-Targeted Drug Active in Advanced/Metastatic Breast Cancerѻýҕl> Durable responses across all three major subtypes of breast cancer Oct 10, 2023
<ѻýҕl>How a Multi-Cancer Screening Test Would Play Out in the Clinicѻýҕl> True positives identified with Grail's assay typically confirmed in under 2 months Oct 10, 2023
<ѻýҕl>Chemo Shortage: 'Paycheck to Paycheck'; Cancer Blood Test Shines; Struggling to Liveѻýҕl> News, features, and commentary about cancer-related issues Oct 06, 2023
<ѻýҕl>Bladder-Sparing Neoadjuvant Protocol Gets High Marks for MIBCѻýҕl> Complete clinical response predicted favorable outcomes for up to 2 years Oct 06, 2023
<ѻýҕl>Sotorasib's Confirmatory Data in NSCLC Unreliable, Says FDA Panelѻýҕl> But agency doesn't plan to immediately push for KRAS inhibitor's withdrawal Oct 05, 2023
<ѻýҕl>Can ctDNA Guide Radiation Use in Oligometastatic NSCLC?ѻýҕl> Detectable circulating tumor DNA before radiotherapy linked with worse survival Oct 05, 2023
<ѻýҕl>FDA Panel Endorses DFMO for Kids' High-Risk Neuroblastoma in Remissionѻýҕl> Large improvement in event-free survival, but questions linger about sources of data Oct 04, 2023
<ѻýҕl>Use of Recent Diagnostic CT Scans for Palliative RT Planning Reduced Treatment Timeѻýҕl> Time to treatment completion slashed by over 4 hours compared with CT simulation planning Oct 04, 2023
<ѻýҕl>Drugmaker Plans to Pull Lung Cancer Therapy From the Marketѻýҕl> Randomized trial of mobocertinib (Exkivity) failed to confirm benefit in rare tumor type Oct 04, 2023
<ѻýҕl>FDA Staff Highly Skeptical of Confirmatory Data on KRAS Inhibitor in NSCLCѻýҕl> Reviewers see potentially tiny PFS benefit with sotorasib, raise concerns over "systemic bias" Oct 04, 2023
<ѻýҕl>Hypofractionated RT for Breast Cancer Post-Mastectomy as Effective as Standard RTѻýҕl> Randomized trial a "game changer" for patients who have implant-based reconstruction, expert says Oct 04, 2023
<ѻýҕl>In BRCA Breast Cancer, Prophylactic Salpingo-Oophorectomy Tied to Better Survivalѻýҕl> PSO should be performed early, particularly for those with the BRCA1 variant, researchers say Oct 04, 2023
<ѻýҕl>SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancerѻýҕl> Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks Oct 03, 2023
<ѻýҕl>FDA Advisors to Consider DFMO Maintenance for High-Risk Neuroblastoma in Kidsѻýҕl> Lack of options for relapsed disease versus uncertainty about supporting data Oct 03, 2023
<ѻýҕl>FDA Greenlights Test for Cancer-Predisposing Genetic Mutationsѻýҕl> First-of-its-kind DNA test achieved 99% accuracy for variants in dozens of genes Oct 03, 2023
<ѻýҕl>Sexual Activity Lowers Risk of Side Effects After Cervical Cancer Treatmentѻýҕl> Intercourse and/or vaginal dilation reduces risk of vaginal stenosis Oct 03, 2023
<ѻýҕl>Preoperative Algorithm Might Halve Unnecessary Oophorectomies in Childrenѻýҕl> Researchers point to potential for reduction in lifelong consequences Oct 03, 2023
<ѻýҕl>ABIM CEO Retirement Comes Amid Wave of Criticismѻýҕl> Richard Baron, MD, plans to step down as pushback against MOC grows Oct 02, 2023
<ѻýҕl>SABR Offers New Hope for Older Patients With Inoperable Kidney Cancerѻýҕl> Phase II study shows 100% local control and cancer-specific survival after more than 3 years Oct 01, 2023
<ѻýҕl>IV Immunoglobulin May Cut Infection Risk of Anti-BCMA Agents for Myelomaѻýҕl> Small retrospective study finds fewer severe infections during periods of replacement therapy Sep 29, 2023
<ѻýҕl>New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancerѻýҕl> Significantly more common in community setting, predicted by high baseline HbA1c Sep 28, 2023
<ѻýҕl>Anti-TIGIT Plus Immunotherapy 'Promising' in NSCLC, Esophageal Cancerѻýҕl> Combination may "provide meaningful antitumor activity," researchers say Sep 28, 2023
<ѻýҕl>Cancer Drug Shortages for Kids; Pharma Agrees to Price Talks; Catch-Up on Screeningѻýҕl> News, features, and commentary about cancer-related issues Sep 28, 2023
<ѻýҕl>Report: Persistence of Gender Inequalities in Cancer Care, and a Call to Actionѻýҕl> Premature deaths, lack of access to services, leadership inequalities highlighted Sep 27, 2023
<ѻýҕl>Cancer Risk in NAFLD Higher With Early Disease Onsetѻýҕl> 52% greater risk of malignancy for patients diagnosed with fatty liver disease before age 45 Sep 27, 2023
<ѻýҕl>SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancerѻýҕl> Combination improved biochemical response and PFS compared with systemic treatment alone Sep 27, 2023
<ѻýҕl>Study Confirms Better Survival for HPV-Positive Cervical Cancerѻýҕl> Source, interpretation of negative tests remain open to speculation Sep 26, 2023
<ѻýҕl>When Screening Guidelines Collide, Who Wins?ѻýҕl> A closer look at conflicting colorectal cancer screening recommendations Sep 26, 2023
<ѻýҕl>Frontline Combo Yields High Remission Rate in Hairy Cell Leukemiaѻýҕl> And almost all complete responders in small trial achieved MRD negativity Sep 25, 2023
<ѻýҕl>Reduced Mortality Seen in Cancer Survivors Who Meet Exercise Guidelinesѻýҕl> Survivors classified as exercisers have 25% reduced risk of all-cause mortality, study shows Sep 23, 2023